SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-054267
Filing Date
2023-11-02
Accepted
2023-11-02 21:26:41
Documents
2
Period of Report
2023-11-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1606
2 POA DOCUMENT poa.txt EX-24 3567
  Complete submission text file 0001209191-23-054267.txt   6573
Mailing Address C/O DIAZ & ALTSCHUL CAPITAL 950 THIRD AVE NEW YORK NY 10022
Business Address
DIAZ REINALDO M (Reporting) CIK: 0001250086 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41855 | Film No.: 231374307

Mailing Address 430 E. 29TH STREET FLOOR 14 NEW YORK NY 10016
Business Address 430 E. 29TH STREET FLOOR 14 NEW YORK NY 10016 (212) 547-9879
Lexeo Therapeutics, Inc. (Issuer) CIK: 0001907108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)